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Abstract  
The impact of integrated reproductive health and HIV services on HIV testing and counselling (HTC) 
uptake was assessed among 882 Kenyan FP clients using a non-randomized cohort design within six 
intervention and six ‘comparison’ facilities. The effect of integration on HTC goals (two tests over two 
years) was assessed using conditional logistic regression to test four ‘integration’ exposures: a training 
and reorganisation intervention; receipt of RH and HIV services at recruitment; a functional measure of 
facility integration at recruitment; and a woman’s cumulative exposure to functionally integrated care 
across different facilities over time. While recent receipt of HTC increased rapidly at intervention 
facilities, achievement of HTC goals was higher at comparison facilities. Only high cumulative exposure 
to integrated care over two years had a significant effect on HTC goals after adjustment (aOR 2.94, 
95%CI 1.73-4.98), and programmes should therefore make efforts to roll-out integrated services to 
ensure repeated contact over time.   
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Background 
The integration of reproductive health (RH) and HIV services is hypothesised to have multiple service- 
and health-related benefits. In addition to increasing cost-effectiveness, it is expected that the co-
location of services under one roof, or within one consultation room, will minimise problematic referral 
processes, increase service uptake, and thus impact on RH and HIV-related behaviours and outcomes 
(Askew and Berer 2003; Sibide and Buse 2009). Robust evidence on these potential benefits, however, 
is lacking. A Cochrane review on the impacts of all types of integrated primary health care found no 
evidence that more integrated services improve healthcare delivery or health status (Dudley and 
Garner 2011). Reviews on the integration of RH and HIV services, specifically, conclude that research 
evidence on outcomes is lacking, with few studies adequately defining and measuring integrated 
services, or comparing integrated with stand-alone health services (Kennedy, Spaulding et al. 2010; 
Lindegren, Kennedy et al. 2012; Wilcher, Hoke et al. 2013).  
One potential benefit of integrated care is increased utilisation of the individual component health 
services. Increasing the uptake of HIV testing and counselling (HTC) is a critical public health goal, since 
the proportion of adults who know their HIV status rarely exceeds 50% in most high- and medium-HIV 
prevalence settings (UNAIDS 2013; UNAIDS 2014). Annual testing rates are even lower, with national 
surveys reporting only around one fifth of women and men receiving a test in the past year (Staveteig, 
Wang et al. 2013). Knowledge of HIV status is an essential pre-requisite to accessing antiretroviral 
therapy (ART) for people living with HIV (PLHIV), and the need to scale-up testing has been asserted in 
new ’90-90-90’ global targets, aiming to have 90% of PLHIV knowing their status, 90% on sustained ART, 
and 90% with viral suppression by the year 2020 (UNAIDS 2014). Knowledge of status also contributes 
to HIV prevention, not only through access to treatment and associated viral suppression, but through 
reductions in the risk of perinatal and onwards sexual transmission (Denison, O'Reilly et al. 2008; 
Kennedy, Fonner et al. 2013).  
Repeated testing every 6-12 months has been recommended by the World Health Organization since 
2007 for those at higher risk of HIV exposure. In Kenya, where current HIV prevalence is estimated at 
6.1% (UNAIDS 2013) and risk of exposure is high, repeat annual testing for those who test negative has 
been recommended since 2010 (NASCOP 2010). However, a national household survey indicated that 
only 29% of women and 23% of men have tested in the past 12 months (Staveteig, Wang et al. 2013). 
Integration between reproductive health and HIV services has been  rolled-out nationally as a strategy 
to promote HIV testing by the Kenyan Ministry of Health (MOPHS 2009; MOPHS 2012).  
Multiple strategies have been designed and evaluated to promote uptake of HTC within generalised 
epidemics. Provider-initiated testing and counselling  (PITC) for HIV is one intervention with proven 
impact on HIV testing uptake when services were integrated  within antenatal care, primary care, STI 
and TB services (Pope, Deluca et al. 2008; Leon, Naidoo et al. 2010; Kennedy, Fonner et al. 2013). A 
systematic review on the implementation of PITC in sub-Saharan Africa, however, found challenges 
with the approach, with levels of test offering and acceptance varying markedly by study setting (Roura, 
Watson-Jones et al. 2013). For maternal and child health (MCH) programmes, promoting HTC within 
antenatal care has remained a focus  as it is an essential strategy to prevent mother-to-child 
transmission (Baggaley, Hensen et al. 2012), and increasingly promoted through the roll-out of the 
Option B+ regimen (Herlihy, Hamomba et al. 2015). Documentation of the integration and promotion of 
HTC within family planning (FP) services is more limited. FP clients are an important target group for 
testing since they are sexually active and usually not current condom users. Evidence on the 
effectiveness of integrating HTC into FP services is limited. One cross-sectional analysis of FP clinic 
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records in Ethiopia compared integration at provider, room and facility levels (i.e. assessing whether 
HTC uptake differed when offered by the same provider, in the same room, or in the same building as 
the FP service) (Bradley, Bedada et al. 2008). Higher HIV testing uptake was found in facilities with 
room- and provider-levels integration. In Kenya’s Central Province, an uncontrolled pre-/post-test 
comparing an ‘integrated’ FP-HTC model (on-site testing) with a ‘referral’ model found increases in 
discussion of HIV during consultations and increases in HIV testing acceptance following a training and 
counselling support intervention, with testing acceptance higher in the ‘on-site’ testing group (Liambila, 
Askew et al. 2009). However, no attempt was made to control for any selection bias in the two study 
populations and the evaluation was conducted over a short period (10 months).  
In their Cochrane review on integrated care, Dudley and Garner underline the complexity in the 
definition and measurement of integrated care, and the need for clear and transparent documentation 
of any integrated intervention being evaluated (Dudley and Garner 2011). In general, most 
interventions involve some degree of care reorganisation, but others have merely provided training 
and/or the provision of equipment (Kennedy, Spaulding et al. 2010; Dudley and Garner 2011). Most fail 
to assess whether integrated care (linked provision by one provider, or at one visit) is actually being 
provided to the client, and outcomes may be associated with interventions that were not fully 
implemented.  
In this paper, we aim to assess the impact of integrating HIV and FP services on the HTC uptake of FP 
clients in Central Province, Kenya, and specifically to test the effect of four different exposure 
definitions of integrated care: an intervention involving training and reorganisation; receipt of both RH 
and HIV services at recruitment; a functional measure of facility integration at recruitment; and a 
woman’s cumulative exposure to functionally integrated care across different facilities over time. The 
research was conducted as part of the Integra Initiative, a large-scale evaluation of RH-HIV service 
integration in Kenya and Swaziland. The Integra Initiative is a registered non-randomised trial: 
ClinicalTrials.gov Identifier: NCT01694862. Integra aims to evaluate the effect of service integration 
within FP and post-natal care settings and is comprised of multiple quantitative and qualitative 
components, including household surveys, cohort studies, facility surveys, and qualitative process 
evaluation (Warren, Mayhew et al. 2012).  
Methods 
Study setting and design 
Integra was implemented in public health facilities in Central and Eastern Provinces in Kenya, and in 
three regions in Swaziland. This report focuses on findings from Central Province in Kenya, where an 
intervention was introduced into six facilities (health centres and hospitals) to strengthen the provision 
of integrated FP-HIV services. Compared to the national average, at the time of the research the region 
had a higher modern contraceptive prevalence (46% vs 67%)(National Bureau of Statistics Kenya 2007) 
and lower HIV prevalence (5.6% vs 3.8%) (NASCOP 2007.).      
Integra originally sought a controlled pre-/post-test (quasi-experimental) design to measure the effect 
of integrated health care in intervention sites. Due to challenges in ensuring programme 
implementation in intervention sites, and the existence of non-Integra integration activities in ‘control’ 
sites, the latter are referred to as ‘comparison sites’, and in this paper we treat the whole sample as a 
cohort to assess the effect of individuals’ exposure to integrated care on HIV testing outcomes.  The 
cohort was female FP clients (aged 15-49 years) attending the six intervention and six comparison 
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facilities. The facilities included six hospitals and six health centres; characteristics are described in 
Table 1.  
 
Intervention sites were selected based on good performance in a previous integration study (Liambila, 
Askew et al. 2009), and high client load (≥100/month). Comparison sites had no provincial policy to 
support provision of routine integrated FP-HIV services before the study, and were selected using a 
pair-wise matching design, with matching based on client load, number of providers qualified and 
currently delivering FP services, and range of services available.  Facilities were selected in different 
districts of the same province to minimise contamination. 
The study intervention is described in detail elsewhere (Warren, Mayhew et al. 2012), but in short it 
was designed to add the following services into standard FP service delivery: discussion of fertility 
desires, condom promotion/provision, STI/HIV risk assessment, HIV status check, HTC provision, 
cervical cancer screening, pre-HIV treatment services and/or referral to HIV treatment unit for HIV+ 
clients. The provision of these services was supported by training on and the provision of an integrated 
client counselling toolkit, the ‘Balanced Counseling Strategy Plus’ (BCS+) (Population Council 2016). In 
addition, intervention facilities were supported by nurse/midwife  ‘mentors’ who were trained as 
mentors and provided training on SRH/HIV technical skills and supportive supervision on integrated 
care (Ndwiga, Abuya et al. 2014). The layout of some clinics was also reorganised to support integrated 
care provision, and essential equipment and supplies were provided to deliver integrated services.  
Data collection 
FP clients were recruited between the end of 2009 and early 2010, and interviewed at four time points 
over two years: baseline (r0) (immediately post- intervention implementation), round 1 (r1) (r0+6 
months); round 2 (r2) (r0+18 months); and round 3 (r3) (r0+24 months). The recruitment interview took 
place at the health facility using a structured questionnaire on a personal digital assistant (PDA), and 
subsequent interviews were conducted either at the respondent’s home or at an arranged meeting at 
the health facility, also using PDAs. The questionnaire was in Kiswahili, and collected data on socio-
demographic characteristics, family planning practices, HIV-related behaviours and practices, service 
use history, and perceptions of service quality. Respondents gave their informed consent before each 
interview.  
At recruitment, clients were sampled consecutively as they exited consultations. Sample size 
calculations were based on having 80% power to detect an absolute between-group increase from 5% 
to 10% in another study outcome (consistent condom use) among those using other contraceptive 
methods. Based on condom use estimates in a previous study (Liambila, Warren et al. 2008; Mwangi, 
Warren et al. 2008) and with a significance level of 5%, it was estimated that 1952 participants would 
be needed, assuming a 30% loss to follow up.  
Study population 
Of the original recruitment sample (N=1958), the following women were excluded sequentially from 
the analysis: 245 with known HIV positive at recruitment (tested either before or during recruitment 
consultation) (139 in intervention (14%) and 106 in comparison (11%); 745 without a complete cohort 
data history (r0 through r3) (345 in intervention (41%) and 400 in comparison (46%); and 86 missing 
complete data on all potentially confounding variables (64 in intervention (13%) and 22 in comparison 
(5%); resulting in sample size of 882 for a complete case analysis.  
6 
 
Measuring the uptake of HIV testing 
At every round, respondents were asked whether they had received an HIV test – during consultation at 
recruitment, or since their last interview in subsequent rounds – and the date of the test. Participants 
who remained HIV-negative (as self-reported in cohort interviews) and received at least two HIV tests 
over the 2 year cohort period were considered to have fulfilled the outcome, ‘HTC goals achieved’, 
since annual testing is the national recommendation in Kenya (NASCOP 2010). Those who reported a 
positive HIV test during the study were categorised as ‘HTC goals achieved’ if they reported at least one 
HIV test during the study.  
 
[Table 1 about here] 
 
Measures of RH-HIV integration 
We investigated the impact of service integration on HTC uptake using four different measures of integrated care. The 
different approaches, summarised in  
Table 2, reflect different a priori questions and mechanisms – at both the facility and individual level - 
by which integration may influence client outcomes, and the fact that there are no standard definitions 
of integration in research or health practice. 
The first measure ‘Design group’ categorised women by the study arm (per protocol), based on whether 
the facility from where they were recruited was designated as an intervention or comparison site. This 
maintains the original quasi-experimental approach.   
Subsequent exposures utilise a cohort study design. The second measure captured each individual 
woman’s actual receipt of integrated services during the recruitment consultation, irrespective of the 
facility’s designation as intervention or comparison site in the study. Services used were self-reported 
by women in the exit interview. “Integrated services” were defined as a visit in which a woman received 
at least one reproductive health service (FP counselling, FP method provision/check-up, post-natal care 
for mother, post-natal care for baby, child health or cervical cancer screening) AND at least one HIV/STI 
service (STI counselling or treatment, HIV counselling, HIV test, HIV treatment and care, psycho-social 
support for HIV, treatment of opportunistic infections, TB service). Since HIV testing forms a part of this 
definition, the outcome measure for this exposure was restricted to HIV tests received in rounds 1-3 
only (excluding r0).  
The third measure recorded the degree of integrated care being delivered at the facility at recruitment, 
as measured by the Integra Functional Integration Index. The Integra Index is a multi-dimensional score 
of facility-level integration derived from data collected through client flow analyses and calculated 
using latent variable modelling (Mayhew, Ploubidis et al. 2016). The Index measures integration as a 
continuum, so that differences in the extent and nature of integration across facilities could be 
understood. It is derived from four indicators capturing the extent to which a facility’s clients receive 
both RH and HIV services during their visits. Index scores at recruitment ranged from 0.87 to 3.42 across 
the 12 facilities; these were categorised into low (≤1.99), medium (2.00 to 2.74), or high (≥2.75) index 
integration scores, based on the distribution of the data.  
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Since women may return for FP consultations differentially, or switch facilities (i.e. visit facilities other 
than the recruitment facility) during the two-year follow up period of the study, and the extent of 
integration at a facility can vary over time, the fourth measure recorded a cumulative integration score 
that took into account each woman’s individual use of integrated clinics throughout the study (as self-
reported by women in each cohort interview). To calculate the cumulative score, Index scores were 
summed for every FP visit reported over the 2 year cohort period, although scores for visits to non-
Integra study facilities were not captured (14% and 16% of FP visits at r2 and r3 respectively). The 
cumulative exposure score was grouped into three categories, low, medium and high, based on tertiles 
of the data (since scores were more evenly distributed across the far wider range of individual scores). 
[Table 2 about here] 
  
Statistical analyses 
Data were imported into STATA 13.0 for cleaning, checking and analysis. We used z tests for differences 
in proportions in HIV testing between cohort rounds, and χ2 tests for crude associations between HIV 
testing and each of the four measures of integration, as well as between potentially confounding 
variables and outcome.  
Potential confounders were identified through a review of the literature of factors influencing HIV testing uptake 
(Kalichman and Simbayi 2003; Zeelie, Bornman et al. 2003; Fylkesnes and Siziya 2004; Warwick 2006; Nakanjako, Kamya et 
al. 2007; Musheke, Ntalasha et al. 2013), and are displayed in the conceptual framework in   
Table 2: Different measures used to define integrated care 
Research question Integration 
exposure measure 
Definition Notes 
1) Does the Integra Intervention have 
an effect on HIV testing uptake 
among FP clients, compared to FP 
clients in facilities which did not 
receive the Integra intervention? 
Design group  Attended intervention or 
comparison facility at the time of 
recruitment visit 
 
6 intervention, 6 
comparison facilities 
2) Does the receipt of integrated RH-
HIV services during a FP visit increase 
annual HIV testing over the 
subsequent two years (regardless of 
study arm)? 
Individual receipt of 
integrated services 
at baseline 
Woman received combination of 
at least one RH service (FP, MCH) 
and one HIV/STI service (HIV 
testing, HIV counselling, STI 
service) during her consultation 
at baseline  
Binary measure (Yes/No) 
HIV testing uptake 
measured at Rounds 1-3 
only (baseline excluded). 
3) Does the level of integration at the 
facility lead to an increase in annual 
HIV testing among FP clients 
(regardless of study arm)? 
Baseline facility 
integration index 
score 
Score derived from Integra 
Functional Integration Index (IFII) 
to measure the extent of 
integration at the facility level 
Low (≤1.99), medium 
(2.00 to 2.74), or high 
(≥2.75) index integration 
score. 
4) Does the cumulative score for the 
level of integration in all facilities 
visited by a woman over 2 years 
influence her uptake of annual HIV 
testing? 
Cumulative 
integration index 
score 
Cumulative index exposure 
(additive score) to capture 
subsequent visits at study clinics 
 
Grouped by tertiles of 
cumulative score into 
low, medium and high.  
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Figure 1. Most of these factors were measured at r0, though selected indicators were recorded at every 
round (‘Becomes pregnant’, ‘Continued use of FP’, ‘>1 sex partner in past 12 months (at any time)’). 
Socio-economic status groupings were based on a principal components analysis of household assets. 
The ‘provider stigma score’ was based on a mean score derived from Likert scales (1-5) on client reports 
on the following clinic characteristics: privacy, confidentiality of consultation, trust in records being kept 
confidential, and people living with HIV (PLHIV) treated same as others. ‘Satisfaction with services’ was 
based on a mean score derived from Likert scales (1-5) on: overall service rating, costs, waiting time, 
availability of drugs and supplies, possibility to receive other services at the same time, opening times, 
provider friendliness, doctor/nurse availability, providers listened, client could ask questions.  
Multivariable analyses were conducted to test the association between integration exposure and achievement of HTC goals, 
to control for potential confounding. We used conditional logistic regression models to account for clustering at facility 
level, including all potential confounders in the model (i.e. theory-driven selection of variables). Potential effect 
modification of the relationship between integration and HIV testing by certain variables (identified conceptually, see  
Table 2: Different measures used to define integrated care 
Research question Integration 
exposure measure 
Definition Notes 
1) Does the Integra Intervention have 
an effect on HIV testing uptake 
among FP clients, compared to FP 
clients in facilities which did not 
receive the Integra intervention? 
Design group  Attended intervention or 
comparison facility at the time of 
recruitment visit 
 
6 intervention, 6 
comparison facilities 
2) Does the receipt of integrated RH-
HIV services during a FP visit increase 
annual HIV testing over the 
subsequent two years (regardless of 
study arm)? 
Individual receipt of 
integrated services 
at baseline 
Woman received combination of 
at least one RH service (FP, MCH) 
and one HIV/STI service (HIV 
testing, HIV counselling, STI 
service) during her consultation 
at baseline  
Binary measure (Yes/No) 
HIV testing uptake 
measured at Rounds 1-3 
only (baseline excluded). 
3) Does the level of integration at the 
facility lead to an increase in annual 
HIV testing among FP clients 
(regardless of study arm)? 
Baseline facility 
integration index 
score 
Score derived from Integra 
Functional Integration Index (IFII) 
to measure the extent of 
integration at the facility level 
Low (≤1.99), medium 
(2.00 to 2.74), or high 
(≥2.75) index integration 
score. 
4) Does the cumulative score for the 
level of integration in all facilities 
visited by a woman over 2 years 
influence her uptake of annual HIV 
testing? 
Cumulative 
integration index 
score 
Cumulative index exposure 
(additive score) to capture 
subsequent visits at study clinics 
 
Grouped by tertiles of 
cumulative score into 
low, medium and high.  
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Figure 1) was tested using the Mantel-Haenzel method, but no effect modification was found (data not 
shown). 
[Figure 1 about here] 
 
Sensitivity analyses 
To examine the effect of facility pair-matching, we also constructed a conditional regression model 
using the STATA svy commands to account for clustering within matched pairs, in addition to the 
conditional dependency on the facility cluster. Analyses that allowed for such clustering (by facility 
pairs) gave almost identical results to those that assumed independence, and the latter are reported. 
Sensitivity analyses were also conducted for missing data on complete cases. We conducted χ2 
statistical tests to assess how those with complete cohort data differed to those with an incomplete 
cohort history across baseline exposure and potential confounding factors. Those with complete data 
differed from those who were excluded from the analysis in age (p<0.001, with those in the youngest 
age group less likely to have complete data), and whether they paid fees for services (p=0.017, those 
paying fees were less likely to have complete data). There was no evidence of a difference in other 
baseline characteristics or between clinics. The implications of these differences are addressed in the 
discussion.  
Results 
Table 3 displays the socio-demographic and service-related characteristics of the study population, in 
aggregate and by design group. Women in intervention clinics were younger (17% were over 35, vs 28% 
at comparison sites), had similar marital patterns (97% of both groups were married), had different 
religious beliefs (with fewer Pentecostals (32% vs 40%)), were more highly educated (10% had received 
some tertiary education vs 3% in comparison sites), had higher self-employment (46% vs 37%) and 
lower manual employment (6% vs 16%), and lived further from their clinic (45% lived over 30 mins away 
vs none in comparison sites). In terms of SRH behaviours, the groups had similar probabilities of 
becoming pregnant or continuing FP over the cohort (16%  vs 12%; and 80% vs 83% respectively); 
intervention participants were less likely to use a voucher for FP (3% vs 6%), but had similar health 
insurance (22% overall). Multiple sexual partnerships were commonly low across the groups (2.4% 
overall), as was condom use at last sex (3.4%). Women in intervention clinics were more likely to make 
decisions on FP over their partner (57% vs 47%). They were more likely to be dissatisfied with services 
(10% vs 5%) and to have waited longer (57% had to wait over 30 mins, vs 0.2% in comparison sites), 
though they were less likely to have paid fees for services (83% vs 93%).   
[Table 3 about here] 
 
Overall, 69.3% of women achieved HIV testing goals over the two year cohort. 30% received two tests, 
28% received three, and 10% received four HIV tests. Reports of HIV testing increased markedly over 
the course of the cohort, from 28% at baseline (during consultation) to 48% at r1, 65% at r2 and 66% at 
r3 (all reported as test since last interview). In the comparison facilities, an average of 48% of 
participants received an HIV test at baseline (48%) (see Figure 2). This increased slightly to 52% at r1 
and jumps to 66% at r2 before a slight reduction to 61% in the final round. In contrast, participants in 
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intervention facilities report far lower levels of HIV testing at recruitment (8%). By r1, reports jumped 
significantly to 45% and continue to increase in r2 (to 64%) and r3, when 72% of women recruited in 
intervention facilities reported receiving an HIV test since their last interview. 
 
[Figure 2 about here] 
 
  
11 
 
Figure 3 displays HIV testing outcomes by the four different exposure measures. Over the course of the 
study, more women in the comparison group (73%) met the HIV testing goal compared to the 
intervention group (65%). Women who received integrated services at baseline – regardless of design 
group - were more likely to receive the two test minimum (after r0) (71%) compared to those who 
didn’t (61%). There was no clear association with baseline integration index score, with those visiting a 
facility with a ‘medium’ integration score most likely to receive the test outcome (75%) vs the high 
(60%) and the low (63%) groups. There was a clearer association with cumulative integration index 
score, with those women with the highest cumulative exposure to integrated services most likely to 
have received the testing requirement (77%) vs the medium score group (71%) and the low group 
(60%).  
[Figure 3 about here] 
For the two exposure measures with a crude positive impact of integration (individual’s receipt of 
integration at baseline and cumulative clinic integration score), we further tested these associations 
through multivariable analyses. Association between individual receipt of integration and achievement 
of HTC goals became non-significant after adjustment (aOR 1.38, 95%CI 0.88-2.18) (data not shown). 
For the cumulative clinic integration score exposure, both crude and adjusted associations between 
integration and HTC goals, as well as with other socio-demographic and service-related covariates, are 
presented in Table 4. After adjustment, there remained strong evidence of association between 
cumulative exposure to integrated clinics and HTC goal achievement: those with medium exposure to 
clinic integration had nearly double the odds of achieving HTC goals than those in the low exposure 
group (aOR 1.92, 95%CI 1.24-2.97), and those in the highest exposure group had nearly three times the 
odds of HTC goal achievement (aOR 2.94, 95%CI 1.73-4.98). Few other co-variates were associated with 
testing uptake (see grey highlights). There was weak evidence that women becoming pregnant 
subsequent to r0 had higher odds of testing uptake (aOR 1.97, 95%CI 0.95-2.68); and those who had 
health insurance at r0 were also more likely to report testing uptake (aOR 1.59, 95%CI 1.05-2.50).  
 
[Table 4 about here] 
 
Discussion 
This analysis has demonstrated the complexity of assessing the effect of health service re-organisation 
on health and behavioural outcomes. The results show that determining whether ‘service integration’ 
impacts on uptake of HIV testing depends on how ‘integration’ is measured. Findings also point to the 
need to articulate a precise definition of the type of integrated service-delivery that is occurring at any 
given clinic if meaningful interpretation is to be achieved.  
An integration intervention had a positive effect on initially increasing HIV testing uptake from very low 
levels immediately post-intervention, as the proportion of FP clients at these facilities who received an 
HIV test increased dramatically over the course of the study, particularly in the first six months after the 
intervention. In contrast, the ‘comparison’ sites provided much higher levels of HIV testing at r0, and 
levels rose moderately over time. The dramatic increase in HIV testing in intervention facilities 
replicates positive results reported in a previous uncontrolled study of a similar intervention in Central 
Province in Kenya (Liambila, Askew et al. 2009). The higher increase in intervention clinics relative to 
comparison sites suggests that the BCS+ was effective in supporting providers to promote HIV testing, 
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in particular where there was a low baseline and potential latent demand for testing (Population 
Council 2016). The BCS+ toolkit is an evidence-based, interactive, client-friendly approach that aims to 
improve contraceptive counseling by addressing a variety of topics relevant to family planning including 
prevention, detection/testing, and treatment of HIV and STIs, postpartum maternal and newborn care, 
and cervical cancer screening. Other provider job aids have been found to be effective in supporting 
integration activities, including screening tools and flip-charts (Kim, Kols et al. 2005; Foreit 2006; 
Baumgartner, Green et al. 2014), and programmes and donors should continue to support their use in 
order to broaden the scope of health consultations. The costs of production of and training on job aids 
can seem prohibitive to programmes, but the existence of proven global or national tools should make 
their adaptation, implementation and/or dissemination easier.  In Kenya, Integra was able to review 
and update existing MoH job aids. Another report from Integra has also pointed to the important role 
played by mentors during the intervention, who helped improve provider knowledge, skills, self-
confidence, and team work (Ndwiga, Abuya et al. 2014).  
We found no difference, however, between attendance at intervention clinics and achievement of total 
testing goals over the 2 year study period, likely due to markedly lower r0 levels of testing in 
intervention sites. One explanation for lower level of HIV testing at intervention sites at r0 may have 
been previous receipt of HIV testing, potentially due to the previous integration support (the Liambila 
et al. study). This is compounded by the fact that prior to 2010 retesting guidance was unclear, and 
annual testing was not made explicit. Since our questionnaire only recorded past testing history among 
those who received an r0 test, it is not possible to contrast or control for baseline differences; but 
among those whose history was recorded, testing levels were indeed far higher in intervention than 
control sites (89.8% vs 50.8%). In addition, ad-hoc programme changes may have blurred the 
categorisation by design groups: in intervention sites there were challenges with test-kit stock-outs and 
in-staff rotation, limiting intervention activities, and in comparison sites initiatives from the Ministry of 
Health and partner agencies were encouraging HTC for the three months around recruitment. Another 
Integra analysis, developing the Integra Indexes, demonstrated that integration scores (i.e. the 
provision of multiple services by one provider, within one consultation or within one visit) did not 
correlate with design group and thus the relatively large observed increase in testing uptake at design 
sites after r0 should be interpreted with caution (Mayhew, Ploubidis et al. 2016). This and other Integra 
analysis showed that health facility structures need to be prepared with equipment and training before 
integration activities can occur, but these structural inputs are not in themselves sufficient to achieved 
integrated service delivery – this depends on staff actions, motivations and support (Mayhew, Ploubidis 
et al. 2016; Mayhew, Sweeney et al. Forthcoming).  
To answer the question of whether ‘integrated services’ impact on testing goals, it has been informative 
to also investigate the impact of integration measured in other ways. We found a crude effect on HTC 
uptake of an individual’s receipt of integrated RH-HIV services at baseline, but not after adjustment. An 
individual’s cumulative exposure to integrated clinics over time, as measured by the multi-dimensional 
index of integration was, however, still significantly associated with testing uptake after adjustment for 
confounding. This implies that women who return frequently for FP services to more integrated clinics 
are more likely to receive their recommended HIV tests, than women who return frequently to less 
integrated clinics. Family planning services often require follow-up visits, but efforts may be required to 
encourage women to return who have either discontinued or opted for long-term reversible or 
permanent contraceptive methods, which would then have beneficial impacts encouraging engagement 
with both the family planning and HIV service components.  
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It was also surprising that so few other socio-demographic or behavioural factors were associated with 
testing uptake. Women who became pregnant were more likely to get tested, reflecting the provision 
of HTC in antenatal care. Interestingly, having health insurance was associated with testing goals, which 
is surprising given the supposedly free provision of HTC and ART in Kenya. Insurance may be promoting 
use of other services, however, which then provide the opportunity for testing promotion. Other 
factors which might have been expected to influence HTC, such as perceived provider stigma, distance 
living from a testing site, socio-economic status and age (Obermeyer and Osborn 2007; Musheke, 
Ntalasha et al. 2013), all had no influence. The fact that this analysis investigated the receipt of at least 
two tests over a two-year period may explain this difference, since existing studies have focused on 
uptake of a first HIV test. Repeat testing is therefore seemingly more heavily influenced by clinic-level 
factors, and this analysis shows that repeated integration exposure is one of them. This therefore 
provides a strong rationale for national health programmes to respond by scaling up the integration of 
HIV testing into FP services. 
In addition to problems associated with categorisation by design group noted above, this analysis has 
other important limitations. Firstly, the quasi-experimental design implies risk of selection bias. 
Unmeasured confounding from other factors affecting testing uptake is plausible, and in particular the 
failure to control to past testing history, as noted above, may have influenced findings. Other factors 
that we could not control for, but which have been shown to influence testing uptake include perceived 
availability of ART at the clinic, perceived risk of HIV infection, physical health symptoms and  death of 
sexual partner and/or child (Musheke, Ntalasha et al. 2013). Nevertheless, most of these other factors 
would not be expected to vary by clinic. Perceived availability of ART is implicitly linked to clinic 
integration score, and therefore could not be included independently. There is also possible selection 
bias in our results due to incomplete cases and loss to follow up. Complete cohort cases differed to 
those lost to follow up across several important variables. Those with incomplete data were younger 
and more likely to have paid fees for services; the former could have resulted in underestimates of 
testing uptake. Since they did not differ by clinic, however, this bias should not have heavily influenced 
effect estimates reported here.  
Secondly, the calculation of the cumulative facility index score has limitations. We were unable to 
calculate scores for visits to non-Integra study facilities, and there were inconsistencies in recording of 
intervening facility visits between cohort rounds. At r1, information was captured on up to five 
intervening consultations, whereas information at r2 and r3 was restricted to the last visit. The effect of 
clinic exposure over time may therefore be underestimated in sites that would be more likely to 
encourage clients to come back more often.  
Lastly, while efforts were made to remove duplicate reporting of HIV testing, our data cleaning 
indicated that respondents struggled to recall or report accurate HIV testing dates. Despite efforts to 
remove duplicate reports (e.g. where reported dates were very similar), there was still scope that tests 
reported in later rounds were duplications of tests reported earlier. Additionally, reporting bias may 
have increased over time with repeated survey rounds, thus potentially contributing to the markedly 
higher rates of testing over the course of the cohort. Reporting bias should not have differed between 
exposures, however.  
Conclusions  
Assessing the impact of organisational changes on service outcomes is complex, and sensitive to 
measurement definition choices. Using a range of measurements our findings show that integrated 
delivery impacts on HIV testing goals if repeated contact with the integrated care delivery is sustained 
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over time. Strategies to integrate HIV testing into FP services must therefore address sustained 
integrated delivery and encouragement of repeat service-use by clients to ensure they achieve their 
routine testing goals. 
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Table 1: Characteristics of study facilities (pre-intervention), by design group 
Design 
group 
Facility code* Type of facility Location Catchment 
population 
Total FP 
clients 
(2009) 
No. nurse/ 
midwives in 
MCH** 
Integration structure in 
2009 (pre intervention) ‡ 
Pair match facility 
code 
Intervention 23 District hospital Urban (city) 560,230 7402 14 HTC done in FP room 4 
3  Provincial hospital Urban 
(town) 
46,707 5804 7 HTC done in FP room 6 
10  Health Centre Peri-urban 
(edge of 
town) 
69,363 5723 6 HTC done in FP room 9 
21  Sub-District 
Hospital 
Urban 
(town) 
46,707 2871 1 HTC done in FP room 25 
14  Health Centre Rural 7,680 1925 3 HTC done within MCH unit, 
sometimes in same room 
13 
2 Health Centre Rural 23,000 2245 0 † HTC in separate room 5 
Comparison 4  District hospital Urban 
(town) 
53,541 5257 8 HTC done in FP room 23 
6 District hospital Urban 
(town) 
308,000 4529 3 HTC done in FP room 3  
9 District Hospital Rural 21,525 2245 3 HTC done within PMTCT, not 
in MCH unit 
10  
25 Health Centre Rural 23,516 1422 3 HTC done in FP room (part 
of PITC) initiative 
21  
13 Health Centre Rural 29,880 3541 6 HTC done within MCH unit 14  
5 Health Centre Rural 12,294 2372 6 HTC done within MCH unit 2 
Source: Integra Periodic Activity Review 2009 (structured tool capturing data on service characteristics and staffing)   
*Code referred to in Mayhew, Ploubidis et al. 2016  **Registered or enrolled;   † Only 1 clinical officer reported  ‡ Intervention facilities had previously received integration support  
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Table 2: Different measures used to define integrated care 
Research question Integration 
exposure measure 
Definition Notes 
1) Does the Integra Intervention have 
an effect on HIV testing uptake 
among FP clients, compared to FP 
clients in facilities which did not 
receive the Integra intervention? 
Design group  Attended intervention or 
comparison facility at the time of 
recruitment visit 
 
6 intervention, 6 
comparison facilities 
2) Does the receipt of integrated RH-
HIV services during a FP visit increase 
annual HIV testing over the 
subsequent two years (regardless of 
study arm)? 
Individual receipt of 
integrated services 
at baseline 
Woman received combination of 
at least one RH service (FP, MCH) 
and one HIV/STI service (HIV 
testing, HIV counselling, STI 
service) during her consultation 
at baseline  
Binary measure (Yes/No) 
HIV testing uptake 
measured at Rounds 1-3 
only (baseline excluded). 
3) Does the level of integration at the 
facility lead to an increase in annual 
HIV testing among FP clients 
(regardless of study arm)? 
Baseline facility 
integration index 
score 
Score derived from Integra 
Functional Integration Index (IFII) 
to measure the extent of 
integration at the facility level 
Low (≤1.99), medium 
(2.00 to 2.74), or high 
(≥2.75) index integration 
score. 
4) Does the cumulative score for the 
level of integration in all facilities 
visited by a woman over 2 years 
influence her uptake of annual HIV 
testing? 
Cumulative 
integration index 
score 
Cumulative index exposure 
(additive score) to capture 
subsequent visits at study clinics 
 
Grouped by tertiles of 
cumulative score into 
low, medium and high.  
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Figure 1: Conceptual framework identifying potential mediators of the relationships between integration and HIV testing 
uptake 
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Table 3: Socio-demographic and health service characteristics of study sample, by design group 
  
N (%) N (%) N (%)
Age group
<25 114 (25.7) 117 (26.7) 231 (26.2)
25-29 109 (24.6) 142 (32.3) 251 (28.5)
30-34 95 (21.4) 107 (24.4) 202 (22.9)
35-39 85 (19.2) 52 (11.8) 137 (15.5)
≥40 40 (9.0) 21 (4.8) 61 (6.9)
Marital status
Single or has boyrfriend/partner 8 (1.8) 9 (2.1) 17 (1.9)
Married 431 (97.3) 427 (97.3) 858 (97.3)
Divorced/separated/widowed 4 (0.9) 3 (0.7) 7 (0.8)
Religion
Protestant 138 (31.2) 155 (35.3) 293 (33.2)
Roman Catholic 104 (23.5) 125 (28.5) 229 (26.0)
Pentecostal 179 (40.4) 141 (32.1) 320 (36.3)
Other/None 22 (5.0) 18 (4.1) 40 (4.5)
Education (highest level)
None/Primary 286 (64.6) 236 (53.8) 522 (59.2)
Secondary 144 (32.5) 161 (36.7) 305 (34.6)
Tertiary 13 (2.9) 42 (9.6) 55 (6.2)
SES Score (quintiles)
1st (poorest) 117 (26.4) 66 (15.0) 183 (20.7)
2nd 99 (22.3) 78 (17.8) 177 (20.1)
3rd 93 (21.0) 82 (18.7) 175 (19.8)
4th 79 (17.8) 93 (21.2) 172 (19.5)
5th (wealthiest) 55 (12.4) 120 (27.3) 175 (19.8)
Employment status
Student/Unemployed 160 (36.1) 152 (34.6) 312 (35.4)
Casual /Informal 32 (7.2) 40 (9.1) 72 (8.2)
Manual 70 (15.8) 24 (5.5) 94 (10.7)
Self-employed 162 (36.6) 201 (45.8) 363 (41.2)
Professional/technical 19 (4.3) 22 (5.0) 41 (4.6)
Time to reach clinic
0-30 minutes 443 (100.0) 241 (54.9) 684 (77.6)
30-60 munutes 0 (0.0) 123 (28.0) 123 (13.9)
>1 hour 0 (0.0) 75 (17.1) 75 (8.5)
Became pregnantduring cohort 53 (12.0) 68 (15.5) 121 (13.7) 0.128
Continued FP through cohort 369 (83.3) 350 (79.7) 719 (81.5) 0.172
Used FP voucher 28 (6.3) 13 (3.0) 41 (4.6) 0.018
Health insurance 89 (20.1) 105 (23.9) 194 (22.0) 0.17
Multiple sexual partners (any cohort round) 12 (2.7) 9 (2.1) 21 (2.4) 0.521
Condom use at last sex 15 (3.4) 15 (3.4) 30 (3.4) 0.98
Who makes FP decisions
Woman decides 207 (46.7) 252 (57.4) 459 (52.0)
Partner or provider decides 53 (12.0) 32 (7.3) 85 (9.6)
Both agree/other 183 (41.3) 155 (35.3) 338 (38.3)
Provider stigmatising behaviour perception (r0)
Low 88 (19.9) 182 (41.5) 270 (30.6)
Medium 335 (75.6) 233 (53.1) 568 (64.4)
High 20 (4.5) 24 (5.5) 44 (5.0)
Satisfaction with services (r0)
High 118 (26.6) 131 (29.8) 249 (28.2)
Medium 304 (68.6) 265 (60.4) 569 (64.5)
Low 21 (4.7) 43 (9.8) 64 (7.3)
Paid fees for services (r0) 411 (92.8) 362 (82.5) 773 (87.6) <0.001
Waiting time
<=30 mins 442 (99.8) 190 (43.3) 632 (71.7)
>30 mins 1 (0.2) 249 (56.7) 250 (28.3)
Total 443 (100.0) 439 (100.0) 882 (100.0)
<0.001
<0.001
<0.001
0.003
<0.001
0.004
0.904
0.05
<0.001
<0.001
InterventionComparison Total P value 
(χ2)
<0.001
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Figure 2: Proportion who report receiving an HIV test since last interview, by round and design group 
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Figure 3: % women achieving HIV testing goals over the 2 year cohort, by different exposure groups (n=882) 
 
  
0 20 40 60 80 100
Comparison
Intervention
No intgt. svcs
Got intgt. services
Low
Medium
High
Low 
Medium
High
Percent of women achieving HIV testing goals
χ2 * p<0.05   **p<0.01 ***p≤0.001
Design group*
Clinic integration 
score (index) r0***
Individual's cumulative 
exposure to integrated 
clinic score (index)***
Individual's receipt of 
integrated services 
at r0**
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Table 4: Multivariable results of association between cumulative integration index score & HIV testing outcome (n=882) 
 
Variable Category N N % cOR 95%CI aOR* 95%CI
Low 294 175 (59.5) 1.00 1.00
Medium 295 210 (71.2) 1.68 (1.19 2.37) 1.92 (1.24 - 2.97)
High 293 226 (77.1) 2.29 (1.60 3.28) 2.94 (1.73 - 4.98)
Age group Under 25 231 169 (73.2) 1.00 1.00
25-29 251 164 (65.3) 0.69 (0.47 1.02) 0.73 (0.47 - 1.12)
30-34 202 138 (68.3) 0.79 (0.52 1.20) 0.88 (0.56 - 1.41)
35-39 137 96 (70.1) 0.86 (0.54 1.37) 0.70 (0.41 - 1.21)
40 and over 61 44 (72.1) 0.95 (0.51 1.78) 0.65 (0.30 - 1.41)
Single or has boyrfriend/partner 17 15 (88.2) 3.39 (0.77 14.92) 3.30 (0.65 - 16.72)
Married 858 591 (68.9) 1.00 1.00
Divorced/separated/widowed 7 5 (71.4) 1.13 (0.22 5.86) 1.81 (0.29 - 11.16)
Religion Protestant 293 203 (69.3) 1.00 1.00
Roman Catholic 229 163 (71.2) 1.09 (0.75 1.60) 1.21 (0.79 - 1.85)
Pentecostal 320 216 (67.5) 0.92 (0.65 1.30) 0.84 (0.57 - 1.25)
Other/None 40 29 (72.5) 1.17 (0.56 2.44) 0.99 (0.42 - 2.32)
 Education None/Primary 522 374 (71.6) 1.00 1.00
Secondary 305 203 (66.6) 0.79 (0.58 1.07) 0.80 (0.56 - 1.16)
Tertiary 55 34 (61.8) 0.64 (0.36 1.14) 0.83 (0.40 - 1.74)
1 183 135 (73.8) 1.00 1.00
2 177 124 (70.1) 0.83 (0.52 1.32) 1.33 (0.78 - 2.27)
3 175 129 (73.7) 1.00 (0.62 1.60) 1.68 (0.95 - 2.99)
4 172 110 (64.0) 0.63 (0.40 0.99) 1.37 (0.76 - 2.45)
5 175 113 (64.6) 0.65 (0.41 1.02) 1.55 (0.81 - 2.96)
Employment status Student/Unemployed 312 213 (68.3) 1.00 1.00
casual worker/Informal sector 72 45 (62.5) 0.77 (0.45 1.32) 0.74 (0.41 - 1.36)
Employed (manual) 94 73 (77.7) 1.62 (0.94 2.77) 0.82 (0.42 - 1.62)
Self-employed 363 256 (70.5) 1.11 (0.80 1.54) 0.84 (0.56 - 1.25)
Employed (professional/technical) 41 24 (58.5) 0.66 (0.34 1.28) 0.67 (0.30 - 1.50)
0-30 minutes 684 473 (69.2) 1.00 1.00
30-60 munutes 123 77 (62.6) 0.75 (0.50 1.11) 0.96 (0.58 - 1.59)
>1 hour 75 61 (81.3) 1.94 (1.06 3.55) 1.33 (0.61 - 2.88)
Became pregnant 
over cohort
No 761 522 (68.6) 1.00 1.00
Yes 121 89 (73.6) 1.27 (0.83 1.96) 1.59 (0.95 - 2.68)
Continued use of FP 
over cohort
No 163 102 (62.6) 0.69 (0.48 0.98) 0.78 (0.50 - 1.24)
Yes 719 509 (70.8) 1.00 1.00
Used FP voucher No 841 578 (68.7) 1.00 1.00
Yes 41 33 (80.5) 1.88 (0.86 4.12) 1.30 (0.53 - 3.18)
Has health insurance No 688 475 (69.0) 1.00 1.00
Yes 194 136 (70.1) 1.05 (0.74 1.49) 1.62 (1.05 - 2.50)
No 861 594 (69.0) 1.00 1.00
Yes 21 17 (81.0) 1.91 (0.64 5.73) 1.88 (0.53 - 6.65)
No 852 590 (69.2) 1.00 1.00
Yes 30 21 (70.0) 1.04 (0.47 2.29) 1.58 (0.65 - 3.88)
Woman decides 459 313 (68.2) 1.00 1.00
Partner/provider decides 85 63 (74.1) 1.34 (0.79 2.25) 1.27 (0.70 - 2.31)
Both agree/other 338 235 (69.5) 1.06 (0.79 1.44) 1.11 (0.78 - 1.57)
Low 270 192 (71.1) 1.00 1.00
Medium 568 385 (67.8) 0.85 (0.62 1.17) 0.81 (0.54 - 1.22)
High 44 34 (77.3) 1.38 (0.65 2.93) 1.22 (0.48 - 3.10)
High 249 175 (70.3) 0.66 (0.34 1.27) 0.94 (0.42 - 2.09)
Medium 569 386 (67.8) 0.59 (0.32 1.10) 0.87 (0.42 - 1.83)
Low 64 50 (78.1) 1.00 1.00
Paid fees r0 No  109 82 (75.2) 1.40 (0.88 2.22) 0.92 (0.48 - 1.76)
Yes 773 529 (68.4) 1.00 1.00
Waiting time r0 <=30 mins 632 447 (70.7) 1.00 1.00
>30 mins 250 164 (65.6) 0.79 (0.58 1.08) 1.31 (0.82 - 2.08)
Condom use at last 
sex
Decision-making on 
FP
Provider stigmatising 
behaviour r0
Satisfaction score r0
*Adjusted for all other variables in table
HIV testing 
Cumulative exposure 
to integration score
Marital status
SES quantile
Distance from clinic 
(travel time)
Multiple sex 
partners 
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